Correct Answer: D. Serum ceruloplasmin
A golden ring on the iris is Kayser-Fleischer ring, the pathognomonic ocular sign of Wilson's disease (hepatolenticular degeneration). This ring represents copper deposition in Descemet's membrane of the cornea, though it appears as a golden-brown discoloration at the iris margin due to the angle of light reflection. Wilson's disease is an autosomal recessive disorder of copper metabolism caused by mutations in the ATP7B gene, leading to impaired biliary copper excretion and toxic accumulation in the liver, brain (basal ganglia), and cornea. The next diagnostic step after identifying Kayser-Fleischer rings is to measure serum ceruloplasmin, which is markedly reduced (typically <20 mg/dL, normal 20–40 mg/dL) in Wilson's disease. Ceruloplasmin is a copper-carrying protein synthesized in the liver; its deficiency allows free copper to accumulate in tissues. This single test, combined with clinical findings and slit-lamp confirmation of the ring, establishes the diagnosis. Subsequent investigations include 24-hour urinary copper (elevated >100 μg/day) and serum free copper, but ceruloplasmin is the first-line biochemical confirmation. Early diagnosis is critical in India, where Wilson's disease prevalence is estimated at 1–2 per million, because treatment with copper chelators (penicillamine) or zinc supplementation can prevent irreversible neurological and hepatic damage.
Why the other options are wrong
A. Serum iron — This is wrong because Kayser-Fleischer rings reflect copper, not iron, deposition. Serum iron is relevant in hemochromatosis (which may cause corneal opacities but not the characteristic golden ring), not Wilson's disease. NBE may trap students who confuse metal metabolism disorders or who think any metallic ring on the iris suggests iron overload. B. Alpha-1-antitrypsin — This is wrong because alpha-1-antitrypsin deficiency causes early-onset emphysema and liver disease, not Kayser-Fleischer rings or copper deposition. While both Wilson's disease and alpha-1-antitrypsin deficiency can present with liver disease, the ocular sign is entirely specific to Wilson's disease. NBE pairs this to test whether students conflate genetic liver diseases. C. Alpha-fetoprotein — This is wrong because AFP is a tumor marker elevated in hepatocellular carcinoma and germ cell tumors, not in Wilson's disease. Although Wilson's disease increases HCC risk due to cirrhosis, the Kayser-Fleischer ring itself is not a marker of malignancy. This is a distractor for students who think 'liver disease = AFP testing.'
High-Yield Facts
- Kayser-Fleischer ring = golden-brown discoloration at iris margin, pathognomonic for Wilson's disease, visible on slit-lamp examination.
- Serum ceruloplasmin <20 mg/dL is the first-line biochemical test for Wilson's disease diagnosis; normal range 20–40 mg/dL.
- ATP7B gene mutation causes defective copper excretion into bile, leading to toxic accumulation in liver, basal ganglia, and cornea.
- 24-hour urinary copper >100 μg/day and serum free copper are confirmatory tests, but ceruloplasmin is the initial screening marker.
- Penicillamine and zinc supplementation are first-line treatments; early diagnosis prevents irreversible neuropsychiatric and hepatic complications.
Mnemonics
Wilson's Disease Triad (WD-Triad) Wilson's disease → Descemet's membrane (Kayser-Fleischer ring) + Decrease in ceruloplasmin + Damage to basal ganglia (movement disorder). Use this to link the ocular sign directly to the biochemical marker and neurological manifestation. Copper Overload → Ceruloplasmin Down In Wilson's disease, copper accumulates because ceruloplasmin (the copper carrier) is deficient—think 'no carrier, copper piles up.' This memory hook explains why measuring ceruloplasmin confirms the diagnosis.
NBE Trap
NBE pairs Kayser-Fleischer rings with other metal metabolism disorders (iron, alpha-1-antitrypsin) to test whether students recognize that this ring is pathognomonic for Wilson's disease and not a generic sign of metal overload or liver disease.
Clinical Pearl
In Indian clinical practice, Wilson's disease often presents in young adults (15–30 years) with either neuropsychiatric symptoms (tremor, dystonia, personality change) or acute hepatitis; the Kayser-Fleischer ring may be the only objective sign in early disease. Slit-lamp examination followed by ceruloplasmin testing can diagnose the condition before irreversible basal ganglia damage occurs, making this a critical screening tool in any young patient with unexplained liver disease or movement disorder.
_Reference: Robbins Ch. 18 (Liver and Biliary Tract); Harrison Ch. 356 (Wilson's Disease); KD Tripathi Ch. 57 (Trace Elements and Toxicology)_